Goodbye Semglee
A long-acting insulin that almost everyone (in the Australian T1 diabetes world anyway) knows of is “Lantus”, even though it was replaced by the identical Optisulin 2 years ago. It took a while to be phased out. A few months prior (back in October 2019) I reported the arrival of “Semglee”. This is marketed by …